Improving Mortality, Heart Failure and Renal Outcomes -the Evidence for SGLT2

Hosted by the Asian Pacific Society of Cardiology

Endorsed by the ISCP

Part of the Asian Pacific Society of Cardiology’s special series of CME-accredited webinars. This edition of the series will discuss how to improve mortality, heart failure and renal outcomes for our patients: is the evidence for SGLT2i enough for a paradigm shift for practicing cardiologists?

Applying SGLT2 trial Results to Improve Cardiac Outcomes: Hospitalization for HF and Death
Prof Felipe A Martinez

Selecting the Right Renal Patients: What Do the Trials Tell Us About SGLT2
Assoc Prof Jimmy Teo

Potential Downsides of SGLT2
Adj Assoc Prof Jack Tan

COVID-19 PCR and Serology: Testing Pros and Cons
Dr Laila Wareth

Panelists Discussion

Adj Assoc Prof Tan Wei Chieh Jack
Deputy Head and Senior Consultant, National Heart Centre Singapore; President, Asian Pacific Society of Cardiology, Singapore

Prof Carolyn Lam
Senior Consultant, Department of Cardiology, Director, Women’s Heart Health, National Heart Centre Singapore
Singapore

Prof Felipe A. Martinez
Emeritus Professor of Medicine, Cordoba National University; Director, Instituto DAMIC-Fundación Rusculleda
Past President, International Society of Cardiovascular Pharmacotherapy, Cordoba, Argentina

Assoc Prof Jimmy Teo
Head & Senior Consultant, Division of Nephrology, Department of Medicine, National University Hospital, Singapore

Dr Laila Abdel Wareth
Chief, Clinical Pathology , Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates

Prof Mark Cooper
Head, Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia

Assoc Prof Jin Joo Park
Associate Professor, Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital
Seoul, South Korea

Prof Eugenio B. Reyes
Clinical Associate Professor, University of Philippines, Department of Internal Medicine, Philippine General Hospital
Past President, Philippine Heart Association, Manila, Philippines

Dr Su-Yen Goh
Head & Senior Consultant, Department of Endocrinology, Singapore General Hospital, Singapore

Adj Assoc Prof Sim Kheng Leng David
Senior Consultant, Department of Cardiology, Director, Heart Failure Programme, National Heart Centre Singapore, Singapore

Dr Roger Tan
Nephrologist, Roger Kidney Clinic, Gleneagles Medical Centre, Singapore

Cardiologists, Endocrinologists, Nephrologists and Trainees

Improving Mortality, Heart Failure and Renal Outcomes -the Evidence for SGLT2

Hosted by the Asian Pacific Society of Cardiology

Endorsed by the ISCP